CTOs on the Move

Brook Health

www.brook.health

 
Get personalized guidance and chat with live health experts any day of the year to help manage or prevent diabetes, lose weight, and boost energy levels
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Manitoba Health Employees Benefits Plan

Manitoba Health Employees Benefits Plan is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.

Access Case Management Services of Georg

Access Case Management Services of Georg is a Savannah, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hollenbeck Home

Serving the Greater Los Angeles area for more than a century, men and women in their senior years have enjoyed Hollenbeck`s vibrant, rewarding and comfortable environment, where friendships grow as personal interests are pursued. Hollenbeck Palms offers independent residential living, assisted residential living and skilled nursing services. Please refer to the main menu to view each of these opportunities for aging-in-place. Give us a call to schedule a convenient time to visit and enjoy an escorted tour of our impressive facilities and a complimentary lunch in our Grand Dining Room.

Autonomic Technologies

Welcome. Autonomic Technologies, Inc. (ATI) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company`s initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache. The ATI Neurostimulation System was voted #2 among the Cleveland Clinic’s top 10 medical innovations for 2013, and Autonomic Technologies was named one of FierceMedicalDevices’ Fierce 15 most promising privately held medical device and diagnostics companies in the world.